Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy
Aziz Zaanan(Université Paris Cité), Frank A. Sinicrope(Mayo Clinic in Arizona)
Cited by 146
Related Papers
DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy
|JNCI Journal of the National Cancer Institute|2011|527
A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening
|New England Journal of Medicine|2024|385
Molecular Biomarkers in the Personalized Treatment of Colorectal Cancer
|Clinical Gastroenterology and Hepatology|2016|115
Sorafenib Inhibits STAT3 Activation to Enhance TRAIL-Mediated Apoptosis in Human Pancreatic Cancer Cells
|Molecular Cancer Therapeutics|2010|93